OpGen OPGN

€ 1.87 -16.95%

Quartalsbericht 2024-Q3
hinzugefügt 15.11.2024

Andere Aktien der Branche "Diagnostik & Forschung"

Name	Preis	% 24h	Marktkapitalisierung	Börse	Land
Fluidigm Corporation FLDM	$ 3.75	1.08 %	$ 308 M	Nasdaq Global Select Market	USA
Global Cord Blood Corporation CO	$ 2.99	-	$ 399 M	NYSE	China
Genetron Holdings Limited GTH	$ 4.03	0.12 %	$ 80.1 M	Nasdaq Global Market	China
Oxford Immunotec Global PLC OXFD	$ 21.99	-	$ 562 M	Nasdaq Global Select Market	Britain
Trinity Biotech plc TRIB	$ 1.24	-4.88 %	$ 61.9 M	Nasdaq Global Select Market	Irlanda
Chembio Diagnostics CEMI	$ 0.46	0.22 %	$ 16.8 M	Nasdaq Capital Market	USA
Bioventus BVS	$ 11.71	1.74 %	$ 734 M	Nasdaq Global Select Market	USA
Meridian Bioscience VIVO	$ 33.97	-	$ 1.49 B	Nasdaq Global Select Market	USA
HTG Molecular Diagnostics HTGM	$ 0.48	-20.0 %	$ 1.06 M	Nasdaq Capital Market	USA
Quotient Limited QTNT	$ 0.32	-11.32 %	$ 1.1 M	Nasdaq Global Select Market	Schweiz
Personalis PSNL	$ 2.17	-14.57 %	$ 102 M	Nasdaq Global Select Market	USA
PRA Health Sciences, Inc. PRAH	$ 165.21	-	$ 10.7 B	Nasdaq Global Select Market	USA
Heska Corporation HSKA	$ 119.99	-	$ 1.31 B	Nasdaq Capital Market,SPB	USA
Agilent Technologies A	$ 133.92	1.41 %	$ 40.7 B	NYSE,SPB	USA
DarioHealth Corp. DRIO	$ 0.91	9.65 %	$ 25.8 M	Nasdaq Capital Market	Israel
Motus GI Holdings MOTS	$ 0.17	-34.28 %	$ 263 K	Nasdaq Global Select Market	Israel
Biocept BIOC	$ 0.43	-13.05 %	$ 7.29 M	Nasdaq Capital Market	USA
PerkinElmer PKI	$ 115.24	-0.91 %	$ 14.7 B	NYSE,SPB	USA
DexCom DXCM	$ 72.62	-2.47 %	$ 28 B	Nasdaq Global Select Market,SPB	USA
Centogene N.V. CNTG	$ 0.33	-6.23 %	$ 30.6 M	Nasdaq Global Market	Germany